Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308724 · ClinicalTrials.gov registry record · NA
Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT00308724: Completed NA study, sponsored by Baylor College of Medicine.
NCT00308724 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 148 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308724, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care setting.
Interventions
- BEHAVIORAL Cognitive Behavior Therapy
- BEHAVIORAL Telephone check-in
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2004-03 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT00308724 record still lists
NCT00308724 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavior Therapy is the first listed.
NCT00308724 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00308724 about?
NCT00308724 is a clinical study titled "Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care". The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care setting.
What is the current status of trial NCT00308724?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2004-03. Estimated completion is 2015-04.
What interventions are being tested in trial NCT00308724?
The interventions under investigation include: Cognitive Behavior Therapy (BEHAVIORAL), Telephone check-in (BEHAVIORAL).
Who is sponsoring clinical trial NCT00308724?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00308724's enrollment target sits among peer trials
148 702nd of 2000 higher than 1,298 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia